Performance/Reporting Period
2022
Value Set Description from VSAC
Clinical Focus: The purpose of this value set is to represent concepts of medications of angiotensin-converting enzyme (ACE) inhibitor, angiotensin-receptor blocker (ARB), and angiotensin receptor-neprilysin inhibitor (ARNI) therapies.
Data Element Scope: This value set may use a model element related to Medication.
Inclusion Criteria: Includes concepts that represent a medication for angiotensin-converting enzyme (ACE) inhibitor, angiotensin-receptor blocker (ARB), and angiotensin receptor-neprilysin inhibitor (ARNI) therapies.s diuretic, ACEI plus calcium channel blocker, ARB plus calcium channel blocker, or ARB plus calcium channel blocker plus diuretic.
Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.
QDM Datatype and Definition